Enzyme Engineering Opens Door to Novel Therapies for Parkinson's, Cancers and Other Hard-to-target Protein Diseases
March 27, 2025
March 27, 2025
LA JOLLA, California, March 27 -- The Scripps Research Institute issued the following news:
* * *
Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases
Researchers reprogrammed a botulinum toxin protease to selectively break down disease-causing proteins in human cells, providing proof of concept for developing new therapies for a wide range of illnesses.
LA JOLLA, CA--Scientist . . .
* * *
Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases
Researchers reprogrammed a botulinum toxin protease to selectively break down disease-causing proteins in human cells, providing proof of concept for developing new therapies for a wide range of illnesses.
LA JOLLA, CA--Scientist . . .